Vermont H 46: An act relating to the creation of the Sports Betting Study Committee

Bill Text

No. 98 Page 1 of 6
2026

VT LEG #389888 v.1
No. 98. An act relating to the Rare Disease Advisory Council.
(H.46)
It is hereby enacted by the General Assembly of the State of Vermont:
Sec. 1. FINDINGS
The General Assembly finds that:
(1) lack of awareness contributes to common and harmful obstacles that
rare disease patients face, such as delays in diagnosis, misdiagnosis, lack of
treatment options, high out-of-pocket costs, and limited access to medical
specialists; and
(2) with the support of the National Organization for Rare Disorders,
various patient organizations, and stakeholders in the rare disease community,
rare disease advisory councils are enabling states to strategically identify and
address barriers that prevent individuals living with rare disease from
accessing adequate and effective treatment and care for their condition.
Sec. 2. 18 V.S.A. chapter 19 is added to read:
CHAPTER 19. RARE DISEASES
§ 981. RARE DISEASE ADVISORY COUNCIL
(a) Creation. There is created the Rare Disease Advisory Council within
the Department of Health to provide guidance and recommendations to the
public, General Assembly, and other government agencies and departments, as
necessary, regarding the needs of individuals living with rare diseases in
Vermont.

No. 98 Page 2 of 6
2026

VT LEG #389888 v.1
(b) Membership.
(1) The Advisory Council shall be composed of the following members:
(A) two individuals living with a rare disease, at least one of whom is
an older Vermonter, appointed by the Commissioner of Health;
(B) a parent or guardian of a person living with a rare disease,
appointed by the Commissioner of Health;
(C) the Commissioner of Health or designee;
(D) the Commissioner of Disabilities, Aging, and Independent Living
or designee;
(E) a representative of the Health Equity Advisory Commission
established pursuant to section 252 of this title;
(F) an academic researcher who conducts rare disease research,
appointed by the Commissioner of Health;
(G) a physician practicing in Vermont with experience treating a rare
disease, appointed by the Vermont Medical Society;
(H) a nurse practicing in Vermont with experience treating a rare
disease, appointed by the Vermont chapter of the American Nurses
Association;
(I) a pharmacist practicing in Vermont, appointed by the Vermont
Pharmacists Association;
(J) a geneticist or genetic counselor, appointed by the Commissioner
of Health; and

No. 98 Page 3 of 6
2026

VT LEG #389888 v.1
(K) any other persons deemed necessary by the Commissioner of
Health.
(2) Members of the Advisory Council shall be appointed for staggered
five-year terms. Any midterm vacancy shall be filled by the appointing
authority for the remainder of the unexpired term. Terms shall begin on
January 1 of the year of appointment and conclude on December 31 of the last
year of the member’s term. Members of the Advisory Council may serve
multiple terms, either consecutively or intermittently.
(3) The Advisory Council may collaborate with any other relevant
stakeholders it deems appropriate, including the National Organization for
Rare Disorders.
(c) Powers and duties. The Advisory Council may conduct the following
activities for the benefit of individuals impacted by rare diseases in Vermont:
(1) convene public hearings and solicit comments from individuals
impacted by rare diseases to assist the Advisory Council with creating a needs
assessment identifying gaps in services for individuals with a rare disease in
Vermont and the needs of their caregivers and providers;
(2) provide testimony and comments on pending legislation and rules
that impact Vermont’s rare disease community before the General Assembly
and other State agencies;
(3) in consultation with experts on rare diseases, develop and provide
policy recommendations that:

No. 98 Page 4 of 6
2026

VT LEG #389888 v.1
(A) identify conditions for the Department of Health to consider as
part of appropriate screening guidance and recommendations; and
(B) support timely patient access to diagnostic services and treatment
and enhance quality of services provided by rare disease specialists; and
(4) any other activities identified by a majority of the Advisory Council.
(d) Assistance. The Advisory Council shall have the administrative,
technical, and legal assistance of the Department of Health. The Department
shall maintain a web page on its website that contains notices of upcoming
meetings, meeting minutes, public comments, and reports.
(e) Report. As needed, the Advisory Council may submit any
recommendations for legislative action to the House Committees on Health
Care and on Human Services and to the Senate Committee on Health and
Welfare.
(f) Meetings.
(1) The Commissioner of Health or designee shall call the first meeting
of the Advisory Council.
(2) Annually, the Advisory Council shall elect a member to serve as the
Chair.
(3) The Advisory Council shall meet quarterly. Meetings may be held
in person or remotely on an electronic platform in accordance